Bispecific Antibodies in Oncology Market Forecast to Surge Over the Next Decade | DelveInsight

Retrieved on: 2025-09-15 22:23:07

Tags for this article:

Click the tags to see associated articles and topics

Bispecific Antibodies in Oncology Market Forecast to Surge Over the Next Decade | DelveInsight. View article details on hiswai:

Excerpt

Volrustomig (MEDI5752) is a monovalent, humanized IgG1 monoclonal antibody that acts as a PD-1/CTLA-4 bispecific inhibitor. It is engineered to ...

Article found on: www.prnewswire.com